400 Participants Needed

Internet-Based Intervention for Young Breast Cancer Survivors

(YES Trial)

Recruiting at 3 trial locations
TO
Overseen ByThe Ohio State University Comprehensive Cancer Center
Age: < 65
Sex: Female
Trial Phase: Academic
Sponsor: Ohio State University Comprehensive Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This clinical trial compares a web-based patient-reported symptom monitoring and self management portal, the Young, Empowered \& Strong (YES), to standard therapy in managing symptoms in adolescent and young adult breast cancer survivors. YES is a web-based portal (website) to help monitor issues or symptoms women with breast cancer may experience. The YES portal may improve the quality of life of young breast cancer survivors. The YES portal may help manage symptoms and provide useful information/resources.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on using a web-based portal to manage symptoms, so it's likely you can continue your current treatments, but you should confirm with the study team.

What data supports the idea that Internet-Based Intervention for Young Breast Cancer Survivors is an effective treatment?

The available research shows that the Internet-Based Intervention for Young Breast Cancer Survivors, like the Sharsheret's Thriving Again program, is effective because most participants found it helpful. Specifically, 94% of women said it helped with cancer treatment, 85% with follow-up, and 91% with discussions with their doctors. Additionally, 75% of women were satisfied with the timing of receiving the support kit. This suggests that the program is beneficial in providing timely and useful support to young breast cancer survivors.12345

What data supports the effectiveness of the Internet-Based Intervention for Young Breast Cancer Survivors treatment?

The evaluation of Sharsheret's Thriving Again program, which is similar to the YES Portal, showed that most young breast cancer survivors found the survivorship care plan helpful for managing treatment and follow-up, with 94% finding it facilitated cancer treatment and 85% finding it useful for follow-up. This suggests that internet-based interventions can be beneficial for young breast cancer survivors.12345

What safety data exists for the Internet-Based Intervention for Young Breast Cancer Survivors?

The provided research does not directly address safety data for the Internet-Based Intervention for Young Breast Cancer Survivors, including the YES Portal. The studies focus on survivorship care planning, fertility issues, program evaluations, and rehabilitation for young breast cancer survivors, but do not specifically mention safety data for the YES intervention or similar programs.12678

Is the Internet-Based Intervention a promising treatment for young breast cancer survivors?

Yes, the Internet-Based Intervention is promising because it offers young breast cancer survivors valuable support and resources. It helps them manage their health, connect with others, and improve their quality of life through online tools and information.29101112

How does the Internet-Based Intervention for Young Breast Cancer Survivors differ from other treatments?

This treatment is unique because it is an online self-help program specifically designed to address the sexual and fertility concerns of young breast cancer survivors, leveraging the familiarity of young people with internet technologies to provide psycho-educational support remotely.29101112

Research Team

MN

Michelle Naughton, PhD

Principal Investigator

Ohio State University Comprehensive Cancer Center

Eligibility Criteria

This trial is for young female breast cancer survivors aged 15-39, within 3 years of a stage 0-III diagnosis. They must be free from recurrence or new cancers (except non-melanoma skin cancer), able to understand English, access their medical records, and willing to use email/text for communication.

Inclusion Criteria

Ability to access medical records from treating hospital
I am mentally capable of following the study's procedures.
I am willing to share my contact details and receive messages from the study team.
See 7 more

Exclusion Criteria

My breast cancer has spread to other parts of my body.
I am either younger than 15 or older than 42.
I am a young woman with breast cancer.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive access to the YES portal or usual care for 9 months, with surveys completed at baseline and 3, 6, and 9 months

9 months
Surveys at baseline, 3, 6, and 9 months

Follow-up

Participants are monitored for sustainability of effects on quality of life and symptoms after the 6-month intervention period

3 months

Open-label extension (optional)

Participants in the usual care group may receive access to the YES portal for an additional 3 months

3 months

Treatment Details

Interventions

  • Young, Empowered & Strong (YES)
Trial Overview The YES portal, a web-based system designed to help monitor symptoms and manage self-care in young breast cancer survivors, is being tested against standard therapy. The goal is to see if it improves quality of life by providing resources and tracking health issues.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Group A (YES portal)Experimental Treatment2 Interventions
Patients receive access to YES portal for 9 months. Patients also complete surveys at baseline and 3, 6, and 9 months.
Group II: Group B (usual care)Active Control2 Interventions
Patients receive usual care for 9 months. Patients also complete surveys at baseline and 3, 6, and 9 months. After 9 months, patients may also receive access to YES portal for 3 months.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ohio State University Comprehensive Cancer Center

Lead Sponsor

Trials
350
Recruited
295,000+

Dana-Farber Cancer Institute

Collaborator

Trials
1,128
Recruited
382,000+

Columbia University

Collaborator

Trials
1,529
Recruited
2,832,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Findings from Research

Young adult cancer survivors (YAS) show high satisfaction with Internet-based survivorship care plans (SCPs), with 93% reporting content satisfaction and 71% sharing their plans with healthcare providers.
Despite experiencing significant late effects like fatigue and neurocognitive concerns, YAS reported fewer late effects overall compared to older adult survivors, suggesting that SCPs may effectively address their specific needs.
Survivorship Care Planning for Young Adults After Cancer Treatment: Understanding Care Patterns and Patient-Reported Outcomes.Szalda, D., Schapira, MM., Jacobs, LA., et al.[2019]
A survey of 163 young breast cancer survivors revealed that 94% found the survivorship care plan (SCP) helpful for managing their treatment and follow-up, indicating its efficacy in supporting their care.
75% of participants were satisfied with the timing of receiving the SCP kit, suggesting that timely access to resources is crucial for enhancing the quality of life for young breast cancer survivors.
"When I Needed It": Evaluation of the Use and Timing of Sharsheret's Thriving Again Program for Young Breast Cancer Survivors.Rohan, EA., Townsend, JS., Fleischmann, A., et al.[2019]
The PARADIGM initiative aims to develop a prognostic classifier specifically for young breast cancer patients (aged ≤40 years) to reduce unnecessary overtreatment, as current tools do not adequately reflect their prognosis.
The study will analyze tumor samples from 3525 young patients diagnosed between 1989 and 2000, using advanced techniques like next-generation sequencing to identify gene expression differences that could inform treatment decisions.
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study.Dackus, GM., Ter Hoeve, ND., Opdam, M., et al.[2022]

References

Survivorship Care Planning for Young Adults After Cancer Treatment: Understanding Care Patterns and Patient-Reported Outcomes. [2019]
"When I Needed It": Evaluation of the Use and Timing of Sharsheret's Thriving Again Program for Young Breast Cancer Survivors. [2019]
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study. [2022]
Active Treatment to Survivorship Care: A Mixed-Methods Study Exploring Resource Needs and Preferences of Young Adult Cancer Survivors in Transition. [2023]
Prognostic factors of young women (≤ 35 years) with node positive breast cancer: possible influence on post-therapeutic follow-up. [2013]
Study protocol for Young & Strong: a cluster randomized design to increase attention to unique issues faced by young women with newly diagnosed breast cancer. [2019]
Comparison of Young Adult Female Cancer Survivors Recruited from a Population-Based Cancer Registry to Eligible Survivors. [2022]
Participating in life again: a mixed-method study on a goal-orientated rehabilitation program for young adult cancer survivors. [2022]
Development of a Self-Help Web-Based Intervention Targeting Young Cancer Patients With Sexual Problems and Fertility Distress in Collaboration With Patient Research Partners. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Web-based self-management for young cancer survivors: consideration of user requirements and barriers to implementation. [2022]
Online information and support needs of young people with cancer: a participatory action research study. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
What Young Women with Breast Cancer Get Versus What They Want in Online Information and Social Media Supports. [2020]